Conference LibraryGated
Brandon (Mojo) · 'lentiviral manufacturing is where antibodies were 25-30 years ago'
Panel 1 上 Brandon(affiliation 自陈 "Mojo")回答主持人关于 cost of goods 与 scalability 的问题时的关键 quote。 这是 m623 在 SunVax pilot proposal / follow-up 话术里可以引用的 strong external anchor —— 说明 LNP / lentiviral manufacturing scalability 当前处于早期阶段,有 10-100x 甚至 1000x productivity 提升空间。 对 SunVax 的相关性: -…
- Type
- quote
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- evidence_grade
- B
- category
- panel_quote_with_attribution
- status
- draft
- instance_tag
- sunvax-antibody-2025
- quote_text
- "If you look back to where antibodies were 25 or 30 years ago, I think that is where lentiviral manufacturing is right now. There is potential for 10-fold or 100-fold improvement — and with antibodies, the improvement has probably been close to 1,000-fold over the last two
- panel
- panel_1
- topic
- lentiviral_manufacturing_scalability
- significance
- Strong external anchor for "LNP/lentiviral manufacturing has massive scalability headroom" framing. m623 in pilot proposal / Demo 2 CMC framing 可引用为 industry-consensus reference.
- speaker_name
- Brandon
- speaker_affiliation
- Mojo
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.